参考文献/References:
[1] 毕晓英 , 王丹丹 , 许珂 .CTLA4 基因多态性与不明原因习惯性流产发生风险关系 [J]. 中国计划生育学杂志 ,2020,28(1):80-84, 92. BI Xiaoying, WANG Dandan, XU Ke. Relationshipbetween CTLA4 gene polymorphism and risk of unexplained habitual abortion occurance [J]. Chinese Journal of Family Planning, 2020, 28 (1): 80-84, 92
[2] 孙娜 , 张文静 , 高飞 , 等 .β2 GP Ⅰ及其抗体与抗磷脂综合征的研究进展 [J]. 现代检验医学杂志,2015,30(1):19-22. SUN Na, ZHANG Wenjing, GAO Fei, et al. Researchprogress ofβ2 glycoprotein Ⅰ and anti-β2GP Ⅰ antibodies and antiphospholipid syndrome [J]. Journal ofModern Laboratory Medicine, 2015,30(1): 19-22.
[3] 张立文 , 谭可为 , 张正燕 , 等 .46, XX, t(7;8) (p21; p21)伴习惯性流产一例[J].现代检验医学杂志, 2008, 23 (2):58. ZHANG Liwen, TAN Kewei, ZHANG Zhengyan, et al.46, XX, t (7; 8) (P21; p21) with a case of habitual abortion[J]. Journal of Modern Laboratory Medicine, 2008,23(2):58.
[4] 吴剑锋.复发性自然流产患者血浆 D- 二聚体、抗凝血酶Ⅲ和蛋白 C 检测的临床意义 [J]. 现代检验医学杂志 ,2018,33(4):112-114. WU Jianfeng. Detection and analysis of D-Dimer,antithrombin Ⅲ and protein C in patients with recurrentspontaneous abortion [J].Journal of Modern LaboratoryMedicine ,2018,33(4):112-114.
[5] 梁静一 , 杜珊 . 淋巴细胞主动免疫治疗习惯性流产 56例临床分析 [J]. 中国妇幼保健 ,2014,29(34):5631-5632. LIANG Jingyi, DU Shan. Clinical analysis of 56 casesof habitual abortion treated with lymphocyte activeimmunotherapy [J]. Maternal & Child Health Care ofChina, 2014, 29 (34): 5631-5632.
[6] 李洁 .2016 年中国“复发性流产诊治的专家共识”与 2017 年欧洲“复发性流产诊治指南”的解读 [J].实用妇产科杂志 , 2018, 34 (11): 822-825. LI Jie. Interpretation of 2016 Chinese expert consensuson diagnosis and treatment of recurrent abortion and2017 European guideline on diagnosis and treatment ofrecurrent abortion [J]. Journal of Practical Obstetricsand Gynecology, 2018, 34 (11): 822-825.
[7] NONAKA T, TOMINAGA M, TAKAHASHI M, et al.Immunotherapy with paternal lymphocytes for patientswith unexplained recurrent abortion and associationwith blocking antibodies:Comparison between patientgroups with primary and secondary unexplained recurrent abortion[J]. Journal of Reproductive Medicine,2018, 63(3): 285-291.
[8] AL-KHABORI M, PATHARE A, MENEGATTI M, etal. Recombinant factor XIII A-subunit in a patient withfactor XIII deficiency and recurrent pregnancy loss[J]. Journal of Thrombosis and Haemostasis: 2018, 16(6):1052-1054.
[9] PETR?NYI G, SIMSA P, PAD?NYI ?, et al. Intravenous immunoglobulin and partner specific thrombocyte transfusion immunotherapy in selected cases of recurrent miscarriage[J]. Journal of Reproductive Medicine,2018, 63(1): 13-20.
[10] HUANG Xiao, QIN Xianhui, YANG Wenbin, et al.MTHFR gene and serum folate interaction on serumhomocysteine lowering: prospect for precision folicacid treatment[J]. Arteriosclerosis Thrombosis and Vascular Biology, 2018, 38(3): 679-685.
[11] 王勉勉 , 李喜梅 , 唐少华 .MTHFR 基因多态性与自然流产的关系 [J]. 中国妇幼保健 ,2017,32(1):92-94. WANG Mianmian, LI Ximei, TANG Shaohua. Relationship between MTHFR gene polymorphism andspontaneous abortion [J]. Maternal & Child HealthCare of China, 2017, 32 (1): 92-94.
[12] 徐佳佳 , 梁玲芝 , 陈贤君 , 等 .MTHFR 基因多态性与先兆流产和复发性流产的关系[J].中国妇幼保健,2019,34(6):1326-1328. XU Jiajia, LIANG Lingzhi, CHEN Xianjun, et al. Relationships between MTHFR gene polymorphism andthreatened abortion, recurrent spontaneous abortion [J].Maternal & Child Health Care of China, 2019, 34 (6):1326-1328.
[13] RENNERT G, RENNERT H S, PINCHEV M, et al.Hormonal and reproductive factors and reduction in therisk of colorectal cancer[J]. European Journal of CancerPrevention, 2020, 29(3): 229-237.
[14] JUNG Y W, AHN E H, KIM J O, et al. Association ofgenetic polymorphisms in VEGF -460, -7 and -583 andhematocrit level with the development of idiopathicrecurrent pregnancy loss and a meta-analysis[J]. TheJournal of Gene Medicine, 2018, 20(9) : e3048.
[15] 王燕 , 林娜 , 陈雪美 , 等 . 反复自然流产患者淋巴细胞主动免疫的治疗效果及其与 HLA 相关性研究 [J].海南医学 ,2018,29(1):59-61. WANG Yan, LIN Na, CHEN Xuemei, et al. Therapeuticeffect of lymphocyte active immunotherapy in recurrent spontaneous abortion patients and its correlation withhuman lymphocyte antigen[J]. Hainan Medical Journal,2018, 29 (1): 59-61.